Jacqueline Tarrant

Jacqueline Tarrant is an experienced leader in the field of clinical biomarkers, currently serving as Senior Director and Global Lead at CSL Behring since December 2019. In this role, Jacqueline oversees the Clinical Biomarker function, acts as a companion diagnostic leader, and collaborates with clinical development, commercial, and research teams. Prior to CSL Behring, Jacqueline held positions at Gilead Sciences, where responsibilities included developing biomarker strategies for kidney disease, NASH, and immunology projects, and had earlier roles at Genentech, Eli Lilly and Company, Royal Veterinary College, and Cornell University, focusing on safety biomarkers, drug efficacy profiling, and clinical pathology. Jacqueline holds a PhD in Medical Biology from the Walter and Eliza Hall Institute, a Masters of Veterinary Studies from the University of Melbourne, and a Bachelor of Veterinary Science from The University of Queensland.